Open Access Open Access  Restricted Access Subscription Access

STUDY OF E.COLI IN CLINICAL SAMPLES, ANTIBIOTIC SENSITIVITY PATTERN AND ESBL PRODUCTION IN A TERTIARY CARE HOSPITAL

Shailja Srivastava, Brij Nandan Singh, A. D. Urhekar, Savita Samant

Abstract


Introduction: Diarrhoea accounts for 1.6-2.5 million deaths annually in children in the developing world experienced an average of 3 episodes of diarrhoea in a year. β- Lactamases continue to be the leading cause of resistance to β-lactam antibiotics among gram-negative bacteria. In recent years there has been an increased incidence and prevalence of extended-spectrum β-lactamases (ESBLs), enzymes that hydrolyse and cause resistance to oxyimino-cephalosporins and aztreonam.

Materials and Methods: Study was done in MGM Medical College & Hospital, Kamothe, Navi Mumbai. The study period ranges from Feb 2012 to Jan 2013. A total number of 3148 clinical samples were analysed and 100 isolates were taken in the study which were positive for E.coli infection. Antimicrobial susceptibility testing was determined to commonly used antibiotics using the modified Kirby-Bauer’s disc diffusion method and ESBL determination was done by the screening test and confirmatory test.

Results: The prevalence of ESBL E.coli was 49%. Out of 49%, the highest rate of Escherichia coli were isolated from pus samples 80%, which was followed by urine 60%. In order to prevent the outbreaks of this life threatening infections caused by ESBL producers, certain infection control measures have to be followed.

Conclusion: The isolates of E.coli were highly resistant to all routine antibiotics with third generation cephalosporins in the hospitalized patients as compared to non-hospitalized patients. Since, ESBL production is more common among the nosocomial pathogens, early detection will definitely help in controlling hospital infections which are caused by this group of organisms.


Keywords


Escherichia coli, UTI, Diarrhoea, ESBL, 3rdgeneration cephalosporins, E coli.

Full Text:

PDF

References


Chatterjee M, Banerjee, Guha S, Lahiri A, and Karak K. (2012). “Study of drug resistance pattern of principal ESBL producing urinary isolates in an urban hospital setting in Eastern India”, Sri Lankan Journal of Infectious Diseases, Vol.1(2), pp.36-41.

CLSI. (2000). “Clinical and Laboratory Standards Institute:2055 guidelines by CLSI/NCCLS-CLSI information supplement”, Approved Standard m100-s15 Wayne, PA;2000, accessed through http://www.microbiolab-bg.com/CLSI.pdf.

Esumeh FI, Isibor JO, and Egbaghe LDS. (2011). “Screening for E.coli O157 : H7 in diarrheic patients in Benin city, Nigeria”, Journal of Microbiology and Biotechnology Research, Vol.1(4), pp.1-4, accessed through http://scholarsresearchlibrary.com/JMB-vol1-iss4/JMB-2011-1-4-1-4.pdf.

Jerlin V, Nicolas MH, Fourvier G, and Philippon A. (1988). “Extended broad-spectrum beta-lactamases and conferring transferable resistance to newer beta-lactam agents in Enterpbacteriaceae: Hospital prevalence and susceptibility patterns”, Rev Infect Dis, Vol.10, pp.867-878.

Kaftandzhieva A, Kotevska V, Jankoska G, Kjurcik-Trajkovska B, Cekovska Z, and Petrovska M. (2009). “Extended-Spectrum Beta-Lactamase-Producing E. Coli and Klebsiella Pneumoniae in Children at University Pediatric Clinic in Skopje”, Macedonian Journal of Medical Sciences, Vol.2(1), pp.38-41, accessed through http://www.mjms.ukim.edu.mk/Online/MJMS_2009_2_1/0030.htm.

Livermore DM. (1995). “β-Lactamases in laboratory and clinical resistance”, Clin. Microbiol. Rev., Vol.8, pp.557-584.

Oyinloye JMA Jnr, and Ezekiel CN. (2011). “Extended-Spectrum Beta-Lactamase (ESBL)-producing Multidrug Resistant Enterobacteria from Commercial Poultry Feeds in Nigeria”, Annals of Biological Research, Vol.2(2), pp.250-254.

Pitout JD, and Laupland KB. (2008). “Extended-spectrum beta-lactamase producing Enterobacteriaceae: an emerging public-health problem”, Lancet Infect. Dis., Vol.8, pp.150-166.

Rajan S, and Prabavathy JV. (2012). “Antibiotic Sensitivity and Phynotypic Detection of ESBL producing E.coli Strains Causing Urinary Tract Infection in a Community Hospital”, WebmedCentral PHARMACEUTICAL SCIENCES 2012;3(11):WMC003840, accessed through https://www.webmedcentral.com/article_view/3840.

Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, Perea EJ, Pérez-Cano R, Hernández JR, and Pascual A. (2006). “Clinical and molecular epidemiology of extended spectrum β-lactamases producing Escherichia coli as a cause of nosocomial infections or colonization: implications for control”, Clin. Infect. Dis., Vol.42, pp.37-45.

Sahu SK, Dalal AS, and Bansal G. (2011). “Detection of extended-spectrum -lactamases in clinical isolates of E. coli and klebsiella species from Udaipur Rajastha”, Biomedical Research, Vol.22(3), accessed through http://www.indmedica.com/journals.php?journalid=12&issueid=150&articleid=2052&action=article.

Suryawanshi NM, Pichare AP, Davane MS, and Deshpande KD. (2011). “Extended Spectrum Beta-Lactamase Producing Escherichia coli at a Tertiary Care Hospital in Maharashtra, India: Phenotypic Detection and Antimicrobial Sensitivity Pattern”, International Journal of Recent Trends in Science And Technology, E-ISSN 2249-8109, Vol.1(2), pp.39-44.

Umadevi S, Kandhakumari G, Joseph NM, Kumar S, Easow JM, Stephens S, and Singh UK. (2011). “Prevalence and antimicrobial susceptibility pattern of ESBL producing Gram Negative Bacilli,” Journal of Clinical and Diagnostic Research, Vol.5(2), pp.236-239.


Refbacks

  • There are currently no refbacks.


Send mail to ijmpr@ijmpr.com with questions or comments about this web site. 

International Journal of Medical and Pharma Research, All rights reserved.